Effect of Stride Management Assist Gait Training for Poststroke Hemiplegia: A Single Center, Open-Label, Randomized Controlled Trial.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 03 06 2018
revised: 11 10 2018
accepted: 18 10 2018
pubmed: 14 11 2018
medline: 29 1 2019
entrez: 14 11 2018
Statut: ppublish

Résumé

Poststroke gait disorders negatively impact activities of daily living. Rehabilitation for stroke patients is aimed at improving their walking ability, balance, and quality of life. Robot-assisted gait training (RAGT) is associated with an increased number of task-specific exercises, which may benefit poststroke motor learning. We investigated the effects of RAGT using Stride Management Assist (SMA, which increases walk ratio by inducing hip-joint flexion and extension) in subacute stroke patients with hemiplegia. We conducted a single center, open-label randomized controlled trial in hemiplegia patients who experienced a first ever stroke and were admitted to the convalescent rehabilitation ward. A total of 41 were divided into the control (20 patients) and experimental group (21 patients). A 10-day, conventional gait training program was carried out for the control group; and RAGT with SMA was used for the experimental group. The maximum walking speed and other gait parameters were compared preintervention and postintervention. The intergroup differences in the improvement ratio were compared using an intention-to-treat analysis. Ten-day intervention was completed by 36 patients. There was no difference between the 2 groups regarding gait parameters at intervention initiation. The improvement ratio of the maximum walking speed was significantly higher for the experimental group. Significant improvements were observed postintervention for maximum walking speed, paralysis-side step length, symmetry, and cadence in the experimental group. No adverse events attributable to the SMA were observed. Ten days of RAGT with the SMA was effective for improving gait disorders of subacute stroke patients.

Sections du résumé

BACKGROUND BACKGROUND
Poststroke gait disorders negatively impact activities of daily living. Rehabilitation for stroke patients is aimed at improving their walking ability, balance, and quality of life. Robot-assisted gait training (RAGT) is associated with an increased number of task-specific exercises, which may benefit poststroke motor learning. We investigated the effects of RAGT using Stride Management Assist (SMA, which increases walk ratio by inducing hip-joint flexion and extension) in subacute stroke patients with hemiplegia.
METHODS METHODS
We conducted a single center, open-label randomized controlled trial in hemiplegia patients who experienced a first ever stroke and were admitted to the convalescent rehabilitation ward. A total of 41 were divided into the control (20 patients) and experimental group (21 patients). A 10-day, conventional gait training program was carried out for the control group; and RAGT with SMA was used for the experimental group. The maximum walking speed and other gait parameters were compared preintervention and postintervention. The intergroup differences in the improvement ratio were compared using an intention-to-treat analysis.
RESULTS RESULTS
Ten-day intervention was completed by 36 patients. There was no difference between the 2 groups regarding gait parameters at intervention initiation. The improvement ratio of the maximum walking speed was significantly higher for the experimental group. Significant improvements were observed postintervention for maximum walking speed, paralysis-side step length, symmetry, and cadence in the experimental group. No adverse events attributable to the SMA were observed.
CONCLUSIONS CONCLUSIONS
Ten days of RAGT with the SMA was effective for improving gait disorders of subacute stroke patients.

Identifiants

pubmed: 30420315
pii: S1052-3057(18)30605-0
doi: 10.1016/j.jstrokecerebrovasdis.2018.10.025
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-486

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Naojiro Tanaka (N)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan; Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: naojirou@live.jp.

Shinro Matsushita (S)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan. Electronic address: bxmbg232@ybb.ne.jp.

Yasushi Sonoda (Y)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan. Electronic address: sonoda88@voice.ocn.ne.jp.

Yoshikatsu Maruta (Y)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan. Electronic address: yoshikatsu_sr425@yahoo.co.jp.

Yuta Fujitaka (Y)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan. Electronic address: fjtk1122@yahoo.co.jp.

Masashi Sato (M)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan. Electronic address: jakee310@hi2.enjoy.ne.jp.

Miki Simomori (M)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan.

Rhyuki Onaka (R)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan.

Keiji Harada (K)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan.

Takashi Hirata (T)

Fundamental Technology Research Center, Honda R&D Co., Ltd., Wako, Japan. Electronic address: Takashi_Hirata@hm.honda.co.jp.

Shoji Kinoshita (S)

Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: kinoshita@jikei.ac.jp.

Takatsugu Okamoto (T)

Department of Rehabilitation Medicine, Nishi-Hiroshima Rehabilitation Hospital, Hiroshima, Japan; Department of Rehabilitation Medicine, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: takatsugu@amy.hi-ho.ne.jp.

Hitoshi Okamura (H)

Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: hokamura@hiroshima-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH